Patient experience of symptoms and side effects when treated with osimertinib for advanced non-small-cell lung cancer: a qualitative interview substudy.

Abstract

Capturing the patient experience during treatment is important to both regulatory authorities and to patients starting treatment. We identified the symptoms and side effects experienced by patients with advanced non-small-cell lung cancer during osimertinib treatment, to understand treatment expectations, satisfaction, and the level of difficulty coping with the side effects experienced during treatment.